Join to View Full Profile
20 York StNew Haven, CT 06510
Phone+1 203-785-4140
Fax+1 203-785-3864
Dr. Emu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2001 - 2004
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1998 - 2001
Johns Hopkins University School of MedicineClass of 1998
Certifications & Licensure
CT State Medical License 2012 - 2026
CA State Medical License 2002 - 2012
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with multidrug resistant HIV-1: A phase 3, multicenter, expanded access study.Brinda Emu, Princy N Kumar, Anthony Mills, Mezgebe Berhe, Brandon R Cash
Journal of Acquired Immune Deficiency Syndromes. 2025-06-04 - Tumor microenvironment of non-small cell lung cancer impairs immune cell function among people with HIV.Shruti S Desai, Syim Salahuddin, Ramsey Yusuf, Kishu Ranjan, Jianlei Gu
The Journal of Clinical Investigation. 2025-06-03 - Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infection.Phillip Chan, Xiang Li, Fangyong Li, Brinda Emu, Richard W Price
Frontiers in Immunology. 2025-01-01
Press Mentions
Ibalizumab Monoclonal Antibody Is Effective in Real-World UseOctober 7th, 2019
HIV Biologic Drug Reduces Viral Load While Boosting ImmunityAugust 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
